LaraKRotter
@LaraKimR
Followers
133
Following
189
Media
3
Statuses
133
Lara K Rotter | PGY-3 | Physician-Scientist Track @YaleIMed | Critical Care/TxID | Former Research Fellow @DanaFarber @harvardme @sloan_kettering
Joined April 2022
New in @AnnalsofIMCC: Researchers describe the challenging diagnosis of an atypical presentation of #legionellosis due to nonserogroup-1 L pneumophila. Read full text for free https://t.co/vp6g9TLaAa
@LaraKimR @YaleMedPTSTP @TradIMYale @YaleIMed @MarkSiegel1
0
1
14
CCADV (CT Alliance and The Connecticut Coalition Against Domestic Violence)
0
0
1
Our first session on Intimate Partner Violence for our residents!A series I was inspired to start by our amazing PD @MarkSiegel1.Grateful for the phenomenal teamwork: Ms.Schippiani(CCADV) and Drs.McNamara, Savage&Sharninghausen.Making a difference together!💪@TradIMYale @YaleIMed
1
3
13
Grateful to be part of this incredible group — our expanding force of Physician-Scientists! @YaleMedPSTP @TradIMYale @MarkDSiegel1
0
4
25
After our recent study on why many clinical trials end prematurely ( https://t.co/cCDSe7q5rd), we set our focus on Global Disparities in Leukemia Clinical Trials ( https://t.co/zcCX5gDPXl).Thanks to our phenomenal team! @Alhajahjeh_Abd @Dr_AmerZeidan... @YaleMedPSTP @MarkDSiegel1
ascopubs.org
PURPOSEMost clinical trials are conducted exclusively in high-income countries (HICs), with only a small fraction involving centers from low-middle income countries (LMICs). However, studies evalua...
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials
0
2
10
No words can express how lucky, grateful our trainees have been to have Dr. Marwan Azar as our program director! Will miss him greatly - wishing you all the success on your next career endeavors!! #IDTwitter #MedTwitter
0
3
21
0
1
3
This is a very critical issue for me especially as one of my friend's brothers has recently passed away due to a lack of access to one of the novel leukemia medications that might help him. I'm thankful for the great support of @Dr_AmerZeidan @MaxStahlMD and @LaraKimR
Just in time for #ASH24; our new paper from @YaleCancer @YaleHematology group examined the Global Disparities in Characteristics & Outcomes of Leukemia Clinical Trials, led by rising 🇯🇴 star @Alhajahjeh_Abd We need more trials in developing countries
0
2
7
Big thanks to @LaraKimR for her phenomenal work and to @Dr_AmerZeidan for the incredible support all the way!! Very excited for the next😁
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials
0
1
7
Our newest paper co-led by our outstanding @YaleMed resident @LaraKimR & 🇯🇴recent graduate @Alhajahjeh_Abd (applying for #Match2025 so program directors plz pay notice) Analyzing determinants of premature trial discontinuation in leukemia clinical trials
tandfonline.com
Clinical trials are crucial for improving patient outcomes. Although a significant number of trials are discontinued prematurely, our understanding of factors influencing early termination is limit...
4
3
38
So excited to join @ColumbiaMed! I have focused my career on supporting the next generation in academic med. The Vagelos Institute for Biomedical Research Education will leverage strengths of @Columbia to build the best environment for physician-scientists from UME to faculty!
We’re excited to welcome Dr. Jay Vyas, as our new Assoc. Dean for Academic Innovation & Director of Physician-Scientist Programs at the Vagelos Institute for Basic Biomedical Science. He'll also join the Division of Infectious Diseases in @CUIMCDeptofMed. https://t.co/VxeiWTLJmG
20
4
160
So proud of @TradIMYale PGY3 @LaraKimR making a splash at IDSA! Watch out NIH! @YaleIMed @YaleIDFellows
Not one, but TWO Challenging Case presentations by the fabulous Maria Koshy (2nd year fellow) and Lara Rotter @LaraKimR (3rd year IM resident) 2/5
0
3
22
Not one, but TWO Challenging Case presentations by the fabulous Maria Koshy (2nd year fellow) and Lara Rotter @LaraKimR (3rd year IM resident) 2/5
1
1
4
Thrilled to have presented a compelling case at the intersection of transplant ID and critical care! Grateful for the inspiring connections and unwavering support and trust, especially from Dr.Marwan Azar.This opportunity truly means a lot! @YaleIDFellows @YaleMedPSTP @TradIMYale
1
4
18
Pics of our beautiful city, just in time for @TradIMYale interview season. @YaleIMed
0
7
72
Looking forward to seeing you all! In the sign-up form, you can drop your questions, and we will be happy to answer them during the events.
Join us for one of three webinars starting tonight for Yale Internal Medicine's Traditional Residency Training Program! @TradIMYale @MarkDSiegel1
0
2
13
Grateful for the opportunity to raise awareness about IPV via @NEJM. IPV is a significant cause of death for women - 1/3 globally, US: 50% female victims killed by current/former partner. IPV is linked to 6% of suicides.
Thank you Lara Rotter @TradIMYale PGY3 for sharing this heartbreaking story. A must read. @TradIMYale @annareisman
https://t.co/PlFQevr9Nk
2
1
11
Thank you Lara Rotter @TradIMYale PGY3 for sharing this heartbreaking story. A must read. @TradIMYale @annareisman
https://t.co/PlFQevr9Nk
nejm.org
When a patient takes offense at her questions about possible intimate partner violence, a physician convinces herself she must set aside her intuitions to retain the patient’s trust.
3
2
30
I am excited to share that I am starting my lab in NHLBI as a Lasker Clinical Research Scholar with the goal of understanding the pathogenesis and developing therapeutics for patients with infections that cause critical illness. @NIHCritCare @TheBethesdaLabs @Raquel_DaCruz
7
6
38